SCNI

MKT CAP:$2M

Scinai Immunotherapeutics Ltd

Market Cap

$2M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.29-$0.44 (-60.11%)

Jun 22, 2026

52W High $2.5252W Low $0.29

Company Details

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatme...

Leadership

Amir Reichman M.B.A., M.Sc.

CEO & Director

Uri Ben-Or CPA, M.B.A.

Chief Financial Officer

Elad Mark B.Sc., Eng., M.B.A.

Chief Operating Officer

Gal Ron

Head of HR

Merav Kamensky

Head of Quality Control & GMP Analytics

Naama Adi Hen

Head of Quality Asurance

Tehila Sonnenfeld

Head of Manufacturing

IPO Date

May 12, 2015

Website

www.scinai.com

Key Metrics TTM

Revenue

$1M

+99.7% YoY

Net Income

-$8M

EPS (Diluted)

Free Cash Flow

-$6M

Revenue / Share

$0.56

Gross Margin

-201.8%

Operating Margin

-574.0%

Net Margin

-632.2%

FCF Margin

-434.2%

P/S

1.4x

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee